Issues and challenges in the assessment, diagnosis and treatment of cardiovascular risk factors: Assessing the needs of cardiologists

BMC Medical Education

Volumn 8, Issue , 2008, Pages

  Hayes, Sean M ^a   Dupuis, Martin ^a   Murray, Suzanne ^a  

^a Axdev   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BEHAVIOR; CARDIOLOGIST; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL PRACTICE; DOCTOR PATIENT RELATION; FEMALE; HUMAN; INTERVIEW; MALE; MEDICAL EDUCATION; NEEDS ASSESSMENT; NORMAL HUMAN; PATIENT MONITORING; PATIENT REFERRAL; PHYSICIAN ATTITUDE; PRIMARY MEDICAL CARE; PROFESSIONAL KNOWLEDGE; QUANTITATIVE ANALYSIS; QUESTIONNAIRE; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SKILL; UNITED STATES; VALIDATION PROCESS; ATTITUDE TO HEALTH; CARDIOLOGY; CLINICAL COMPETENCE; HEALTH PERSONNEL ATTITUDE; HUMAN RELATION; METHODOLOGY; MIDDLE AGED; ORGANIZATION AND MANAGEMENT; SELF CONCEPT; TREATMENT OUTCOME;

ADULT; ATTITUDE OF HEALTH PERSONNEL; CARDIOLOGY; CARDIOVASCULAR DISEASES; CLINICAL COMPETENCE; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MALE; MIDDLE AGED; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); PHYSICIAN'S PRACTICE PATTERNS; PROFESSIONAL-PATIENT RELATIONS; QUESTIONNAIRES; REFERRAL AND CONSULTATION; RESEARCH DESIGN; SELF EFFICACY; UNITED STATES;

EID: 44849105196     PISSN: None     EISSN: 14726920     Source Type: Journal    
DOI: 10.1186/1472-6920-8-30     Document Type: Article

References (23)

1. rd Bethesda Conference. Preventive cardiology: how can we do better? GF Fletcher GJ Balady RA Vogel on behalf of 33rd Bethesda Conference participants, J Am Coll Cardiol 2002 40 579 651 10.1016/S0735-1097(02)02080-6
2. Cardiovascular protection and blood pressure reduction: a meta-analysis. JA Staessen JG Wang L Thijs, Lancet 2001 358 1305 1315 10.1016/S0140-6736(01) 06411-X 11684211
3. Effect of HMG-CoA reductase inhibitors on stroke. A meta-analysis of randomized, controlled trials. HC Bucher LE Griffith GH Guyatt, Ann Intern Med 1998 128 89 95 9441587
4. Effect of statins on risk of coronary disease: a meta-analysis of randomized controlled trials. JC LaRosa J He S Vupputuri, JAMA 1999 282 2340 2346 10.1001/jama.282.24.2340 10612322
5. Physical fitness and activity as separate heart disease risk factors: a meta-analysis. PT Williams, Med Sci Sports Exerc 2001 33 754 761 11323544
6. Cost-effectiveness analysis of intensive blood-glucose control with metformin in overweight patients with type II diabetes (UKPDS No. 51). P Clarke A Gray A Adler, Diabetologia 2001 44 298 304 10.1007/s001250051617 11317659
7. Lifetime health and economic benefits of weight loss among obese persons. G Oster D Thompson J Edelsberg AP Bird GA Colditz, Am J Public Health 1999 89 1536 1542 10511836
8. A clinical practice guideline for treating tobacco use and dependence: a US public health service report. The Tobacco Use and Dependence Clinical Practice Guideline Panel, Staff, and Consortium Representatives, JAMA 2000 283 3244 3254 10.1001/jama.283.24.3244 10866874
9. Use and cost effectiveness of smoking-cessation services under four insurance plans in a health maintenance organization. SJ Curry LC Grothaus T McAfee C Pabiniak, N Engl J Med 1998 339 673 679 10.1056/NEJM199809033391006 9725926
10. Prediction of coronary heart disease using risk factor categories. PW Wilson RB D'Agostino D Levy, Circulation 1998 97 1837 1847 9603539
11. Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations. A statement for healthcare professionals from the American Heart Association and the American College of Cardiology. SM Grundy R Pasternak P Greenland, J Am Coll Cardiol 1999 34 1348 1359 10.1016/S0735-1097(99)00387-3 10520820
12. Guide to primary prevention of cardiovascular diseases. A statement for healthcare professionals from the Task Force on Risk Reduction. SM Grundy GJ Balady MH Criqui, Circulation American Heart Association Science Advisory and Coordinating Committee 1997 95 2329 2331 9142014
13. AHA conference proceedings. Prevention conference V: Beyond secondary prevention: identifying the high-risk patient for primary prevention: executive summary. SC Smith Jr P Greenland SM Grundy, Circulation American Heart Association 2000 101 111 116 10618313
14. MQ Patton, Qualitative Evaluation and Research Methods Newbury Park: Sage 2 1990
15. MQ Patton, Utilization Focused Evaluation: The New Century Text Thousand Oaks: Sage 3 1997
16. JW Creswell, Research Design: Qualitative, quantitative, and mixed approaches Thousand Oaks: Sage 2003
17. A Tashakkori C Teddlie (Eds), Handbook of mixed methods in social and behavioral research Thousand Oaks: Sage 2003
18. Evidence on "what works": an argument for extended-term mixed-method (ETMM) evaluation designs. M Chatterji, Educational Researcher 2005 34 14 24 10.3102/0013189X034005014
19. Communication breakdown in the outpatient referral process. TK Gandhi DF Sittig M Franklin AJ Sussman DG Fairchild DW Bates, J Gen Intern Med 2005 15 9 626 31 10.1046/j.1525-1497.2000.91119.x
20. Determinants and impact of generalist-specialist communication about pediatric outpatient referrals. CJ Stille TJ McLaughlin WA Primack KM Mazor RC Wasserman, Pediactrics 2006 118 4 1341 9 10.1542/peds.2005-3010
21. Surgeons' attitudes about communicating with patients and their families. MJ Sise CB Sise DI Sack M Goerhing, Curr Surg 2006 63 3 213 8 10.1016/j.cursur.2005.08.007 16757376
22. Communicating evidence for participatory decision making. RM Epstein BS Alper TE Quill, JAMA 2004 291 19 2359 2366 10.1001/jama.291.19.2359 15150208
23. Accuracy of physician self-assessment compared with observed measures of competence. DA Davis PE Mazmanian M Fordis RV Harrison KE Thorpe L Perrier, JAMA 2006 296 1094 1102 10.1001/jama.296.9.1094 16954489